Page 2 - Taiwanese (TAIEX) Growth Pharmaceuticals & Biotech Stocks

UPDATED Nov 27, 2024

Discover Taiwanese Pharmaceuticals & Biotech Growth Stocks that are on the TAIEX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

127 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

4170

Vectorite Biomedical
NT$15.000%n/aNT$656.6mn/aPS12.3xn/an/a

6610

TWi Biotechnology
NT$13.25-4.0%-13.4%NT$1.2bn/aPB4.8xn/an/a

8279

Syngen BiotechLtd
NT$131.000.8%-15.5%NT$3.6bn/aPE14.9xn/a3.8%

1720

Standard Chemical & Pharmaceutical
NT$64.000.6%-4.3%NT$11.4bNT$80.00PE13.5xn/a4.2%

6973

U-Neuron Biomedical
NT$39.30-0.1%-6.4%NT$1.2bn/an/an/an/a

6539

DV Biomed
NT$66.800%-54.1%NT$1.4bn/aPE26.2xn/a3.0%

4119

SCI Pharmtech
NT$94.70-3.2%5.1%NT$11.4bn/aPE23.4xn/a1.3%

6794

UnicoCell Biomed
NT$73.901.2%-16.4%NT$4.3bn/aPS148.4xn/an/a

4133

Abnova (Taiwan)
NT$28.900%-20.1%NT$1.7bn/aPE29.7xn/a2.5%

6848

RBC Bioscience
NT$19.50-0.3%20.4%NT$253.0mn/aPE14.7xn/a5.7%

4192

SynCore BiotechnologyLtd
NT$35.85-1.0%-3.0%NT$1.3bn/aPE3463.3xn/an/a

6461

Intech Biopharm
NT$26.95-0.9%-2.2%NT$3.7bn/aPS109.1xn/an/a

6932

Mercury Biopharmaceutical
NT$13.00-1.1%-35.0%NT$5.4bn/aPS943.8xn/an/a

4117

General Biologicals
NT$16.60-6.2%-38.7%NT$1.0bn/aPS4.2xn/an/a

8432

TSH Biopharm
NT$65.001.9%27.2%NT$2.5bn/aPE20.9xn/a2.0%

6817

Winston Medical Supply
NT$89.000.3%-18.3%NT$1.6bn/aPE10.9xn/a7.4%

4105

TTY Biopharm
NT$74.001.4%-11.9%NT$18.4bn/aPE16.4xn/a4.7%

3705

YungShin Global Holding
NT$56.30-2.6%20.0%NT$15.0bn/aPE14.6xn/a4.1%

7754

AnnJi Pharmaceutical
NT$32.65-1.1%n/aNT$3.1bn/aPS16.8xn/an/a

6864

Anti-Microbial Savior BioteQ
NT$58.40-3.2%123.3%NT$1.5bn/an/an/an/a

6483

Original BioMedicals
NT$14.056.8%n/aNT$927.2mn/aPS21562.5xn/an/a

6935

Prince Pharmaceutical
NT$21.95-0.7%-36.9%NT$803.5mn/aPS1.1xn/a1.1%

4169

TCM Biotech International
NT$59.500.2%2.2%NT$3.5bNT$113.00PE175.6xn/a0.5%

4166

Orient Pharma
NT$35.65-9.5%77.4%NT$8.0bn/aPE66.8xn/an/a
Page 2 of 6
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.